Hamid Ahanchian

Dr. Hamid Ahanchian


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Environmental Health Perspectives
Verified
Journal Article
Open access
WSWilliam A. Suk
William A. Suk
HAHamid Ahanchian
Hamid Ahanchian
KAKwadwo Ansong Asante
Kwadwo Ansong Asante
DCDavid O. Carpenter
David O. Carpenter
FDFernando Diaz-Barriga
Fernando Diaz-Barriga
PLPhilip J. Landrigan
Philip J. Landrigan
Summary: Exposures to environmental pollutants during windows of developmental vulnerability in early life can cause disease and death in infancy and childhood as well as chronic, non-communicable diseases that may manifest at any point across the life span. Patterns of pollution and pollution-related disease change as countries move through economic development. Environmental pollution is now recognized as a major cause of morbidity and mortality in low- and middle-income countries (LMICs). According to the World Health Organization, pollution is responsible for 8.9 million deaths around the world each year; of these, 94% (8.4 million) are in LMICs. Toxic chemical pollution is growing into a major threat to children’s health in LMICs. The disease and disability caused by environmental pollution have great economic costs, and these costs can undercut trajectories of national development. To combat pollution, improved programs of public health and environmental protection are needed in countries at every level of development. Pollution control strategies and technologies that have been developed in high-income countries must now be transferred to LMICs to assist these emerging economies to avoid the mistakes of the past. A new international clearinghouse is needed to define and track the health effects of pollution, quantify the economic costs of these effects, and direct much needed attention to environmental pollution as a risk factor for disease.

25 March 2014 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
AAAsghar Aghamohammadi
Asghar Aghamohammadi
PMPayam Mohammadinejad
Payam Mohammadinejad
Hassan AbolhassaniHassan Abolhassani
Hassan Abolhassani
BMBabak Mirminachi
Babak Mirminachi
MMMasoud Movahedi
Masoud Movahedi
NRNima Rezaei
Nima Rezaei

17 June 2016 in Annals of Global Health
Verified
Journal Article
Open access
PLPhilip J. Landrigan
Philip J. Landrigan
JSJ. Leith Sly
J. Leith Sly
MRMathuros Ruchirawat
Mathuros Ruchirawat
ESEmerson R. Silva
Emerson R. Silva
XHXia Huo
Xia Huo
PSPeter D Sly
Peter D Sly
Environmental pollution is a major cause of disease and death. Exposures in early life are especially dangerous. Patterns of exposure vary greatly across countries. In low-income and lower middle income countries (LMICs), infectious, maternal, neonatal, and nutritional diseases are still major contributors to disease burden. By contrast, in upper middle income and high-income countries noncommunicable diseases predominate. To examine patterns of environmental exposure and disease and to relate these patterns to levels of income and development, we obtained publically available data in 12 countries at different levels of development through a global network of World Health Organization Collaborating Centres in Children's Environmental Health. Pollution exposures in early life contribute to both patterns. Chemical and pesticide pollution are increasing, especially in LMICs. Hazardous wastes, including electronic waste, are accumulating. Pollution-related chronic diseases are becoming epidemic. Future Global Burden of Disease estimates must pay increased attention to the short- and long-term consequences of environmental pollution.

24 June 2014 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
PDF file
HKHamidreza Kianifar
Hamidreza Kianifar
HAHamid Ahanchian
Hamid Ahanchian
Zubin GroverZubin Grover
Zubin Grover
SJSeyedali Jafari
Seyedali Jafari
ZNZeinab Noorbakhsh
Zeinab Noorbakhsh
MKMohammadali Kiani
Mohammadali Kiani

13 September 2012 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
HAHamid Ahanchian
Hamid Ahanchian
CJCarmen M Jones
Carmen M Jones
YCYueh-Sheng Chen
Yueh-Sheng Chen
PSPeter D Sly
Peter D Sly
Background: Asthma is a major public health problem with a huge social and economic burden affecting 300 million people worldwide. Viral respiratory infections are the major cause of acute asthma exacerbations and may contribute to asthma inception in high risk young children with susceptible genetic background. Acute exacerbations are associated with decreased lung growth or accelerated loss of lung function and, as such, add substantially to both the cost and morbidity associated with asthma. Discussion: While the importance of preventing viral infection is well established, preventive strategies have not been well explored. Good personal hygiene, hand-washing and avoidance of cigarette smoke are likely to reduce respiratory viral infections. Eating a healthy balanced diet, active probiotic supplements and bacterial-derived products, such as OM-85, may reduce recurrent infections in susceptible children. There are no practical anti-viral therapies currently available that are suitable for widespread use. Summary: Hand hygiene is the best measure to prevent the common cold. A healthy balanced diet, active probiotic supplements and immunostimulant OM-85 may reduce recurrent infections in asthmatic children.

1 January 2017 in International Journal of Preventive Medicine
Verified
Journal Article
Open access
PDF file
TMTooba Momen
Tooba Momen
HAHamid Ahanchian
Hamid Ahanchian
MRMohsen Reisi
Mohsen Reisi
SSSeyedeh Azra Shamsdin
Seyedeh Azra Shamsdin
ASArmindokht Shahsanai
Armindokht Shahsanai
MKMajid Keivanfar
Majid Keivanfar
Background: The relation between interleukin-33 (IL-33) and asthma is not precisely known yet. The present study set to compare the serum level of IL-33 in patients with asthma and controls and study the relation with the severity of disease. Methods: The serum level of IL-33 and total IgE in 89 asthmatic patients and 57 controls were analyzed. The association of levels of IL-33 with the severity of disease, levels of total IgE, measures of spirometry (forced expiratory volume in 1 s [FEV1]), age, sex, presence or absence of other allergic diseases, and the disease duration was evaluated. Results: Higher levels of IL-33 and total IgE were detected in asthmatic patients compared with controls (P = 0.0001 and P = 0.008, respectively). In the asthmatic group, a significant direct association of IL-33 with age (P = 0.02, R = 0.23) and with total IgE level (P = 0.003, R = 0.31) were observed, but there was no relationship between other variables. Comparison of mean level of IL-33 in different asthma groups concerning the disease severity showed the statistically significant difference between them and a significant increased serum level of total IgE was observed in more severe disease. The results showed a significant negative correlation between FEV1 and total IgE (P = 0.028, R = −0.23) and IL-33 level (P = 0.0001, R = −0.83). Conclusions: IL-33 is suggested as a new inflammatory marker of severe and refractory asthma. Therefore, it may be a unique therapeutic target in these patients.